- News in Brief
- Published:
volume 41, page 4 (2023)Cite this article
Currently in the UK, heel prick tests screen for nine specific conditions in newborns. The new program, the largest of its kind in the world, will sequence the genomes of 100,000 newborn babies. The aim is to define whether whole-genome sequencing can detect 200 disorders that affect 3,000 babies born each year in the UK. The focus will be on conditions where interventions exist that could reduce disability or potentially avoid harm; for example, dietary shifts or vitamin supplements, says Mark Caulfield, vice-principal for health for the Faculty of Medicine and Dentistry at Queen Mary University of London, who leads the program. The program will be voluntary and run alongside the heel prick test.
This is a preview of subscription content, access via your institution
Access options
Subscribe to Nature+
Get immediate online access to Nature and 55 other Nature journal
Subscribe to Journal
Get full journal access for 1 year
$99.00
only $8.25 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Tax calculation will be finalised during checkout.
Buy article
Get time limited or full article access on ReadCube.
$32.00
All prices are NET prices.
Rights and permissions
About this article
Cite this article
UK launches whole-genome sequencing pilot for babies.
Nat Biotechnol 41, 4 (2023). https://doi.org/10.1038/s41587-022-01644-0
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41587-022-01644-0
Read More
Tama Wiers
